1996
DOI: 10.1006/rtph.1996.0138
|View full text |Cite
|
Sign up to set email alerts
|

A Parallelogram Approach for Safety Evaluation of Ingested Acetaldehyde

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2000
2000
2023
2023

Publication Types

Select...
4
3
3

Relationship

1
9

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…From these data a total acetaldehyde exposure of 48–96 mg/day (0.64–1.28 mg/kg bodyweight (bw)/day) can be extrapolated (see also [14]). The US Flavor and Extract Manufacturers Association (FEMA) has estimated the possible average daily intake as 35 mg (0.47 mg/kg bw/day) [53] while Morris et al [54] estimated a range of 40–80 mg (0.53–1.07 mg/kg bw/day), with worst case levels up to 200 mg (2.67 mg/kg bw/day) [55]. …”
Section: Resultsmentioning
confidence: 99%
“…From these data a total acetaldehyde exposure of 48–96 mg/day (0.64–1.28 mg/kg bodyweight (bw)/day) can be extrapolated (see also [14]). The US Flavor and Extract Manufacturers Association (FEMA) has estimated the possible average daily intake as 35 mg (0.47 mg/kg bw/day) [53] while Morris et al [54] estimated a range of 40–80 mg (0.53–1.07 mg/kg bw/day), with worst case levels up to 200 mg (2.67 mg/kg bw/day) [55]. …”
Section: Resultsmentioning
confidence: 99%
“…Morris et al, 1996); however, these approaches are typically less well developed than those used to evaluate the potential risk of systemic effects. Risk assessment approaches have been developed to evaluate the potential for some adverse local effects occurring following exposure to toxic compounds (e.g.…”
Section: Challenges and Future Directionsmentioning
confidence: 99%
“…The dose associated with portal-of-entry effects or local effects seen at the site where the toxic compound fi rst contacts the body (i.e., nasal mucosa in an inhalation study) does not typically serve as the basis for route-to-route extrapolations of dose, with some exceptions (e.g., Morris et al ., 1996). The dose associated with portal-of-entry effects or local effects seen at the site where the toxic compound fi rst contacts the body (i.e., nasal mucosa in an inhalation study) does not typically serve as the basis for route-to-route extrapolations of dose, with some exceptions (e.g., Morris et al ., 1996).…”
Section: Route-to-route Extrapolation Of Dosementioning
confidence: 99%